Latest Insider Transactions at Atara Biotherapeutics, Inc. (ATRA)
This section provides a real-time view of insider transactions for Atara Biotherapeutics, Inc. (ATRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Atara Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Atara Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2023
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+34.34%
|
-
|
|
May 31
2023
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+23.13%
|
-
|
|
May 31
2023
|
Maria Grazia Roncarolo |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+39.18%
|
-
|
|
May 16
2023
|
Eric J Hyllengren EVP, CFO and COO |
SELL
Open market or private sale
|
Direct |
7,918
-1.7%
|
$15,836
$2.04 P/Share
|
|
May 16
2023
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
29,766
-3.97%
|
$59,532
$2.04 P/Share
|
|
May 16
2023
|
Charlene A. Banard EVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
19,040
-6.45%
|
$38,080
$2.04 P/Share
|
|
May 16
2023
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,389
-1.51%
|
$16,778
$2.04 P/Share
|
|
Mar 02
2023
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
5,074
-1.72%
|
$15,222
$3.63 P/Share
|
|
Mar 02
2023
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,871
-3.64%
|
$20,613
$3.63 P/Share
|
|
Mar 02
2023
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,221
-1.49%
|
$12,663
$3.63 P/Share
|
|
Mar 02
2023
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
15,679
-2.05%
|
$47,037
$3.63 P/Share
|
|
Mar 01
2023
|
Amar Murugan EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155,375
+35.4%
|
-
|
|
Mar 01
2023
|
Jakob Dupont EVP, Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
141,328
+32.33%
|
-
|
|
Mar 01
2023
|
Charlene A. Banard EVP, Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139,700
+32.13%
|
-
|
|
Mar 01
2023
|
Pascal Touchon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
324,711
+29.76%
|
-
|
|
Feb 07
2023
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,485
-1.3%
|
$12,425
$5.46 P/Share
|
|
Nov 16
2022
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,255
-1.59%
|
$25,020
$4.49 P/Share
|
|
Nov 16
2022
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,612
-2.75%
|
$14,448
$4.49 P/Share
|
|
Nov 16
2022
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
15,591
-3.41%
|
$62,364
$4.49 P/Share
|
|
Nov 16
2022
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
4,342
-1.37%
|
$17,368
$4.49 P/Share
|
|
Aug 16
2022
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
14,806
-3.14%
|
$74,030
$5.04 P/Share
|
|
Aug 16
2022
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
4,124
-2.53%
|
$20,620
$5.03 P/Share
|
|
Aug 16
2022
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,430
-1.28%
|
$17,150
$5.04 P/Share
|
|
Aug 16
2022
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,940
-2.92%
|
$29,700
$5.04 P/Share
|
|
Jun 27
2022
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
14,220
-2.92%
|
$99,540
$7.2 P/Share
|
|
Jun 23
2022
|
Beth C Seidenberg |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+25.89%
|
-
|
|
Jun 23
2022
|
Ronald C Renaud Jr |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+39.42%
|
-
|
|
Jun 23
2022
|
Eric Dobmeier |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+25.63%
|
-
|
|
Jun 23
2022
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+32.03%
|
-
|
|
Jun 23
2022
|
Maria Grazia Roncarolo |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+39.42%
|
-
|
|
Jun 23
2022
|
Ameet Mallik |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+50.0%
|
-
|
|
Jun 23
2022
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+28.28%
|
-
|
|
Jun 23
2022
|
William K Heiden |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+28.28%
|
-
|
|
Jun 23
2022
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+13.41%
|
-
|
|
Jun 08
2022
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,853
-2.8%
|
$29,265
$5.63 P/Share
|
|
May 17
2022
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
13,913
-2.78%
|
$69,565
$5.32 P/Share
|
|
May 17
2022
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
3,873
-2.32%
|
$19,365
$5.32 P/Share
|
|
May 17
2022
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,582
-1.31%
|
$27,910
$5.32 P/Share
|
|
May 17
2022
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,223
-1.18%
|
$16,115
$5.32 P/Share
|
|
Mar 01
2022
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,577
-0.93%
|
$23,193
$9.86 P/Share
|
|
Mar 01
2022
|
Amar Murugan EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,814
+27.08%
|
-
|
|
Mar 01
2022
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
8,828
-1.73%
|
$79,452
$9.86 P/Share
|
|
Mar 01
2022
|
Pascal Touchon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
180,565
+26.18%
|
-
|
|
Mar 01
2022
|
Kristin Yarema Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,533
+20.99%
|
-
|
|
Mar 01
2022
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
2,221
-1.31%
|
$19,989
$9.86 P/Share
|
|
Mar 01
2022
|
Jakob Dupont EVP, Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
78,506
+31.71%
|
-
|
|
Mar 01
2022
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,763
-0.87%
|
$33,867
$9.86 P/Share
|
|
Mar 01
2022
|
Utpal Koppikar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,235
+22.01%
|
-
|
|
Feb 10
2022
|
Jakob Dupont EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-5.23%
|
$80,000
$16.0 P/Share
|
|
Feb 10
2022
|
Jakob Dupont EVP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.97%
|
$45,000
$9.58 P/Share
|